ReviewBiology of reproduction2026
"Old and new" frontiers in embryo viability assessment: current practices and introduction of emerging approaches.
Review in Biology of reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reliable assessment of embryo viability remains a critical yet challenging component of assisted reproductive technologies (ART). Traditional methods, including morphological grading and preimplantation genetic testing for aneuploidy (PGT-A), are either subjective, invasive, or resource intensive. Consequently, non-invasive approaches, including analysis of spent culture medium (SCM) and digital image-based analytical methods, emerged as promising alternatives to support clinical decision-making, though their reliability varies. SCM analyses can detect embryonic DNA and metabolites, but their outcomes are constrained by potential contamination with non-embryonic material and inconsistent amplification efficiency. In contrast, image-based assessment combined with machine learning (ML) enables quantitative, repeatable, and transparent evaluation of embryo architecture. Segmental image analysis of grayscale bitmaps allows for extraction of interpretable phototextural metrics, which have been correlated with developmental competence and ploidy status of embryos. Recent applications of ML-assisted techniques demonstrate comparable or superior predictive performance relative to PGT-A and expert embryologists, highlighting their potential as cost-effective and ethically favorable alternatives. Continued refinement of image acquisition minimizing artifacts, optimizing quality and resolution, and focusing on key regions such as the trophectoderm and inner cell mass, may further enhance their diagnostic sensitivity and specificity. Overall, computerized assessment of embryo microphotographs represents a scalable, non-invasive strategy that can complement or even partially replace invasive testing. By leveraging structured, interpretable image data, algorithms such as r-Algo 2.0 (discriminative image-analysis software) exemplify the emerging role of computational tools in advancing diagnostic precision and objectivity in ART. Highlights Current methods of embryo viability assessment lack clinical reliabilityNon-invasive image analysis supports accurate embryo quality assessmentTransparent algorithms enhance repeatability of image-analysis techniquesImage-based embryo assessments may complement or reduce the need for PGT-AImaging refinements can further enhance its diagnostic sensitivity and specificity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.